HIV-1 (B Gag) Peptide Pool, STEMCELL Technologies (CAT#: STEM-CT-0824-ZJF)

Stimulating T cells with HIV-1 (B Gag) Peptide Pool releases downstream cytokines and upregulates activation markers, enabling antigen-specific T cells to be detected or isolated for analysis. HIV-1 (B Gag) Peptide Pool is a lyophilized mixture of 123 peptides from the gag polyprotein of human immunodeficiency virus 1 (HIV-1). The pool consists of 15-mer peptides with 11-amino-acid overlaps that cover amino acids 1 - 500 on gag polyprotein. The HIV-1 gag polyprotein is a key mediator of viral particle assembly (Campbell & Rein; Dong et al.), and together with the endosomal sorting complexes required for transport (ESCRT), results in budding during virion release (Carlson et al.). Viral peptide pools are useful for a broad range of applications, including vaccine development, immunological research, and diagnostic assay development.

Subtype: Peptide Pools
Species: Other
Application: Activation, Cell Culture
Area of Interest: Infectious Diseases
Purity: Average 70%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

EBV (EBNA-3B) Peptide Pool, STEMCELL Technologies
EBV (EBNA-3A) Peptide Pool, STEMCELL Technologies
HIV (HLA Class I Control) Peptide Pool, STEMCELL Technologies
SARS-CoV-2 (Spike Protein) Omicron/B.1.1.529 WT Reference Peptide Pool, STEMCELL Technologies